Product Information

ENTRESTO 97 MG-103 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.5954 per EA under NDC 00078069620. Its NADAC has been published 549 times since Dec 23, 2015.

The High Outlier badge above means this manufacturer's average price in the Sacubitril and Valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ENTRESTO 97 MG-103 MG TABLET

Sacubitril and Valsartan
$11.5954per EA
High Outlier

Strength

97; 103 mg/1; mg/1

NDC

00078069620

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

SACUBITRIL; VALSARTAN

Approval Type

New Drug (NDA)

FDA Application

NDA207620

On Market Since

7/7/2015

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Neprilysin Inhibitor
Neprilysin Inhibitors

Price Statistics

The NADAC for ENTRESTO 97 MG-103 MG TABLET has been published 549 times since Dec 23, 2015, and over the history we have for it it has risen 93.3%. The table below summarizes its recorded NADAC range and movement.

Current price$11.5954 per EA
All-time high$11.5995 (May 13, 2026)
All-time low$5.9993 (Dec 23, 2015)
52-week high$11.5995
52-week low$11.2514
Median price$9.3141
Average price$9.0518
Largest weekly change+9.9% (Jan 23, 2019)
Weeks tracked549
Tracking sinceDec 23, 2015

Price History

1W

0.0%

1M

+0.1%

3M

-0.0%

6M

+3.0%

1Y

+3.1%

3Y

+8.4%

5Y

+24.5%

All

+93.3%

Generic Alternatives

The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ENTRESTO 97 MG-103 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENTRESTO 97 MG-103 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $11.5954 per EA (NDC 00078069620), effective Jun 24, 2026.

How has the price of ENTRESTO 97 MG-103 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENTRESTO 97 MG-103 MG TABLET has risen 93.3%. It has been tracked across 549 weekly CMS publications since Dec 23, 2015.

What are the highest and lowest recorded NADAC prices for ENTRESTO 97 MG-103 MG TABLET?

Since Dec 23, 2015, the NADAC for ENTRESTO 97 MG-103 MG TABLET has ranged from a low of $5.9993 (Dec 23, 2015) to a high of $11.5995 (May 13, 2026), with a median of $9.3141 per EA.

Are there cheaper alternatives to ENTRESTO 97 MG-103 MG TABLET?

Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SACUBITRIL-VALSARTAN 97-103 MG, is $0.5859 per EA — about 95% below ENTRESTO 97 MG-103 MG TABLET.

Who manufactures ENTRESTO 97 MG-103 MG TABLET?

ENTRESTO 97 MG-103 MG TABLET (NDC 00078069620) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.